Crypto stocks rally after Trump lays out plans for strategic reserve
** Cryptocurrency and blockchain-related stocks rise before the bell after President Donald Trump sets plans for new U.S. strategic reserve
** On Sun, Trump said in a post on Truth Social that bitcoin and ether will be at the heart of a new crypto reserve that would include a range of tokens such as XRP, solana and cardano
** It was the first time the U.S. President had named which assets would be involved
** Bitcoin BTC=, world's biggest cryptocurrency, tumbled on Fri to lowest levels since Nov amid global risk-off sentiment, and had been sliding for weeks on disappointment Trump had not followed through on pledges to loosen regulation
** BTC, which jumped nearly 10% on Sun, last off ~1% at $93,060
** Ether ETH=, which rose ~13% on Sun, last off ~6% to around $2,370
** Shares of bitcoin hoarder Strategy MSTR.O, formerly known as MicroStrategy, surges 13% premarket
** Crypto exchange Coinbase Global COIN.O up ~10%, while U.S.-listed shares of blockchain farm operator Bitfarms BITF.O up 11%
** Crypto miners lift: Riot Platforms RIOT.O , Mara Holdings MARA.O,, Hut 8 HUT.O and Bit Digital BTBT.O all up in range of 8.5%-10.5%
** ProShares Bitcoin Strategy ETF BITO.P and iShares Bitcoin Trust ETF IBIT.O both up >10%
** In 2024, BTC more than doubled in value
Related Articles
BoE August Rate Decision Commentary: Where Next for the Pound?
TradingKey - On 7 August 2025, the Bank of England (BoE) lowered its benchmark interest rate from 4.25% to 4%, aligning with broad market expectations. Notably, the decision sparked significant division within the committee, requiring two rounds of voting to pass.
MP Materials 2Q25 Earnings Comment: Going up the Value Chain
TradingKey - MP Materials released its earnings for the second quarter of the fiscal 2025 on August 7th after the bell.The smaller loss and the better revenue were surely welcomed by investors, and the stock is up 8.50% in the post-bell session.
Eli Lilly’s Q2 2025 Triumph: Soaring Revenue, Plunging Stock – What’s Behind the Paradox?
TradingKey - Eli Lilly released its Q2 2025 financial results, demonstrating impressive financial performance. However, despite the stellar results, its stock price plummeted by over 14%, closing at approximately $640, down more than 30% from its yearly high..jpg)
Caution on Short-Term Downside Risks for U.S. Stock Market
TradingKey - Last Friday, the U.S. Labor Department sharply revised downward its May and June nonfarm payroll figures by a combined 258,000 jobs, a reduction exceeding 90%. Meanwhile, July’s payroll increase came in at just 73,000, falling short of the 100,000 forecast.
From Ozempic to Wegovy: Growth and Risks Behind Novo Nordisk’s Q2 Performance
TradingKey - Novo Nordisk achieved revenue of $11.67 billion in Q2 of the 2025 fiscal year, a 19% increase year-over-year, but it fell short of market expectations. Growth was primarily driven by strong performance in obesity care and rare diseases.
